A common antibiotic may be as effective as oestrogen in preventing devastating bone loss caused by osteoporosis, suggests a new study conducted in the US. Minocycline, a derivative of tetracycline, not only appears to forestall bone loss but also develop bone density. The study, by C T Liang of the National Institute of Aging in Baltimore, conducted on rats, has immediately prompted the National Institutes of Health, Bethesda, to support a clinical trial on humans (Nature Medicine@ Vol 3, No 3).
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.